Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCI-779 in Locally Advanced or Metastatic Pancreatic Cancer
NCT00075647Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 2003
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temsirolimus in pancreatic cancer (PC), sponsored by National Cancer Institute. Started Dec 2003; status: completed.
02
Drugs
temsirolimus
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00075647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075647.